（Last updated : 2020-05-12 12:11:21）
Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
Deciduoid type malignant pleural mesothelioma: a case report
Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
A case report of intrapulmonary schwannoma.
Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
Case of pleural metastasis of prostate cancer.
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
Role of 2-[18F]Fluoro-2-deoxyglucose positron emission tomography in Preoperative Management of Solid-Type Small-Sized Lung Cancer
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant
Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
Current status of Radiologic Diagnosis for Mediastinal
Lymph Node Metastases of Non-Small-Cell Lung Cancer:
Retrospective Study of pN2 Cases
Successful Two-Stage Surgical Treatment for Lung Cancer in a Patient with Contralateral Giant Emphysematous Bullae
Characteristics of Non-Small Cell Lung Cancer Located in the Right Middle Lobe According to a Retrospective Study of Recurrence and Prognosis
Membrane-bound Estrogen Receptor-alpha Expression and Epidermal Growth Factor Receptor Mutation are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients
Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma
A clinicopathological and immunohistological re-evaluation of adenosquamous carcinoma of the lung
Interstitial lung disease after re-administration of gefitinib in a responder with no adverse effects during the first administration: a case report
Disseminated calcifying tumor of the pleura; review of the literature and a case report with immmunohistochemical study of its histogenesis.
Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: 11-years of experience
Display 5 items
JAK-STAT inhibitor overcomes interferon g-reduced, NK cell-mediated cytotoxicity in non-small-cell lung cancer cells.
Clinical effectiveness of perioperative multi-disciplinary team management for lung cancer surgery
3D-complete VATS curative resection for NSCLC
Analysis of intraoperative critical situations in thoracoscopic surgery for NSCLC
Adjuvant chemotherapy is effective for completely resected stage IB non-small cell lung cancer
Local treatment for patients with oligometastatic non-small-cell lung cancer
Prognostic Value of Cox-2 Expression Differs Depending on Tummor CD8+ T Lymphocytes and PD-L1 Expression in Resected Lung Adenocarcinoma.
Relationship between PD-L1 expression and EGFR/HER2 signaling in non-small-cell lung cancer
Induction Therapy followed by Surgery for Borderline Resectable cN2 NSCLC
Survival of non-small cell lung cancer patients predicted from expression of PD-L1, HLA class I and MICA/B on tumor cells
Comparison of Clinicopathological and Immunohistochemical features in Lung Invasive Mucinous Adenocarcinomaaccording to Computed Tomography Findings.
Repeated exposure to cisplatin enhances NK cell-mediated cytotoxicity via up-regulation of NKG2D ligands in non-small cell lung cancer cells
Overexpression of NK cell-activating ligand MICA/B correlates with superior outcomes and might be a therapeutic target for chemo-immunotherapy in non-small-cell lung cancer.
Evaluation of Novel Electronic Chest Drainage System after Anatomical Pulmonary Resection
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells
COX-2 Genetic Variants Influence Intratumoral Infiltration of Foxp-3-Positive Regulatory T Cells in Non-Small Cell Lung Cancer
The effects of pre-clinical clerkship lectures by Essential Medical Skill Ed ucation Team
Attempt of medical education using a high-performance simulator at Kawasaki Medical School and affiliated hospital
Challenge to Conversion Surgery for Locally Advanced Non-Small Cell Lung Cancer
Current state of induction therapy followed by surgery for locally advanced NSCLC
Cytotoxic anticancer drug enhances NK cell-mediated cytotoxicity via the DNA stress induced NKG2D ligands in non-small-cell lung cancer cells
Attempt of medical education using a high-performance simulator at Kawasaki Medical School
Cytotoxic drugs and EGFR tyrosine kinase inhibitor effect on NK cell cytotoxicity in non-small-cell lung cancer cells
EGFR signaling effects on NK cell-mediated cytotoxicity via NKG2D ligands-NKG2D interaction in non-small cell lung cancer cells
Perioperative management of anticoagulant and antiplatelet therapy for radical surgery of lung cancer
Anticancer drugs effect on NK cell-mediated cytotoxicity via the regulation of NKG2D ligand expression in non-small cell lung cancer cells
Post-recurrence survival and prognostic factors in completely resected non-small cell lung cancer
HER signaling effects on the NK cell-mediated cytotoxicity via regulation of MHC class I-related chain A/ B in cancer cells
Biomarker Expression of Primary Non-small Cell Lung Cancer and Metastatic Lympn Nodes
Display 5 items
The International Association for the Study of Lung Cancer (IASLC)
© 2008 Kawasaki Medical School